John Strelow

John Strelow is the Executive Director of Early Molecule Discovery at Eli Lilly and Company, where they lead initiatives in molecular pharmacology. With experience spanning various roles at Eli Lilly, including Senior Director and Principal Research Scientist, John has spearheaded teams in drug discovery, particularly focusing on covalent inhibitors and mechanistic biochemistry. They have a strong background in enzymology and have significantly influenced oncology strategies and novel enzyme inhibitors throughout their career. Previously, John worked at GSK as a Scientist and Senior Scientist, contributing to small molecule protease inhibitor discovery.